Melanoma Research

Papers
(The H4-Index of Melanoma Research is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Rurality as a predictor of melanoma stage and treatment in Indiana: a retrospective cohort study55
Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases36
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting29
Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan26
Genetic concordance in melanoma: insights from primary tumors and their matched distant metastases21
CTLA-4 and TNFRSF1B genetic variants in clinicopathological aspects and outcome of cutaneous melanoma20
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors20
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel20
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study19
Scalp melanoma presents with greater Breslow thickness and higher metastatic burden: analysis of 105 Korean cutaneous head and neck melanoma patients16
Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model15
Assessment of lipid and pigment content in suspicious melanocytic lesions to improve melanoma detection14
Do cortisol and psychological distress levels impact the effectiveness of immunotherapy in patients with metastasized melanoma? A pilot study13
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy13
Brain metastases during follow-up of patients with resected cutaneous melanoma13
Chromosome 1p13.2 gene cluster upregulation in neuroblastoma RAS viral oncogene homolog pathogenic variant melanoma: a potential biomarker axis13
0.26028513908386